NovaBay appoints new CEO, CFO

NovaBay Pharmaceuticals has named Justin Hall as its new president and CEO and Jason Raleigh as its new chief financial officer, according to a press release.

The two have served in interim CEO and CFO roles since March.

"Justin and Jason have proven their leadership abilities by successfully implementing the shift in our U.S. commercial strategy we announced in March and executing the recent launch of our U.S. direct-to-consumer sales of Avenova on Amazon.com," said Paul E. Freiman, chairman of NovaBay.

 

NovaBay Pharmaceuticals has named Justin Hall as its new president and CEO and Jason Raleigh as its new chief financial officer, according to a press release.

The two have served in interim CEO and CFO roles since March.

"Justin and Jason have proven their leadership abilities by successfully implementing the shift in our U.S. commercial strategy we announced in March and executing the recent launch of our U.S. direct-to-consumer sales of Avenova on Amazon.com," said Paul E. Freiman, chairman of NovaBay.